For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Phase I Study of the Safety and Tolerability of ATR-101 in Adrenocortical Carcinoma
Adrenal Cancer ( Malignant neoplasm of adrenal gland )
Location of study visits: Ann Arbor, MI
This study will evaluate the safety of an investigational drug calledATR-101 administered in adult participants with adrenocortical cancer that have failed standard chemotherapy.
This study is looking for: male   female  Both men and women
  • Volunteers with specific conditions
  • More than 18 years old
This study will evaluate the safety of an investigational drug calledATR-101 administered in adult participants with adrenocortical cancer that have failed standard chemotherapy.
HEROES needed for this study I am interested Print Study | Email Study
Who can participate?
What is involved? A participant in a Phase I clinical study has completed approved therapies for their cancer, and may be a candidate for participation in an experimental study. A potential participant for this study will need to be evaluated by a University of Michigan medical oncologist, and assessed for eligibility for this study. This study has strict criteria for participation with limited enrollment.
Compensation This study does not offer any compensation.
We respect your privacy! UMClinicalStudies.org is a secure, password-protected database. All the information that you choose to share will be kept private and confidential. Read University of Michigan's Notice of Privacy Practices.